Literature DB >> 31917153

Attenuated dopamine receptor signaling in nucleus accumbens core in a rat model of chemically-induced neuropathy.

Dana E Selley1, Matthew F Lazenka2, Laura J Sim-Selley2, Julie R Secor McVoy2, David N Potter3, Elena H Chartoff3, William A Carlezon3, S Stevens Negus2.   

Abstract

Neuropathy is major source of chronic pain that can be caused by mechanically or chemically induced nerve injury. Intraplantar formalin injection produces local necrosis over a two-week period and has been used to model neuropathy in rats. To determine whether neuropathy alters dopamine (DA) receptor responsiveness in mesolimbic brain regions, we examined dopamine D1-like and D2-like receptor (D1/2R) signaling and expression in male rats 14 days after bilateral intraplantar formalin injections into both rear paws. D2R-mediated G-protein activation and expression of the D2R long, but not short, isoform were reduced in nucleus accumbens (NAc) core, but not in NAc shell, caudate-putamen or ventral tegmental area of formalin- compared to saline-treated rats. In addition, D1R-stimulated adenylyl cyclase activity was also reduced in NAc core, but not in NAc shell or prefrontal cortex, of formalin-treated rats, whereas D1R expression was unaffected. Other proteins involved in dopamine neurotransmission, including dopamine uptake transporter and tyrosine hydroxylase, were unaffected by formalin treatment. In behavioral tests, the potency of a D2R agonist to suppress intracranial self-stimulation (ICSS) was decreased in formalin-treated rats, whereas D1R agonist effects were not altered. The combination of reduced D2R expression and signaling in NAc core with reduced suppression of ICSS responding by a D2R agonist suggest a reduction in D2 autoreceptor function. Altogether, these results indicate that intraplantar formalin produces attenuation of highly specific DA receptor signaling processes in NAc core of male rats and suggest the development of a neuropathy-induced allostatic state in both pre- and post-synaptic DA receptor function.
Copyright © 2020. Published by Elsevier Ltd.

Entities:  

Keywords:  Adenylyl cyclase; Autoreceptor; Dopamine; G-protein; Neuropathic pain; Nucleus accumbens

Year:  2020        PMID: 31917153      PMCID: PMC7654441          DOI: 10.1016/j.neuropharm.2020.107935

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  61 in total

1.  Δ9-tetrahydrocannabinol and endocannabinoid degradative enzyme inhibitors attenuate intracranial self-stimulation in mice.

Authors:  Jason M Wiebelhaus; Travis W Grim; Robert A Owens; Matthew F Lazenka; Laura J Sim-Selley; Rehab A Abdullah; Micah J Niphakis; Robert E Vann; Benjamin F Cravatt; Jenny L Wiley; S Stevens Negus; Aron H Lichtman
Journal:  J Pharmacol Exp Ther       Date:  2014-11-14       Impact factor: 4.030

Review 2.  Basal ganglia circuit loops, dopamine and motivation: A review and enquiry.

Authors:  Satoshi Ikemoto; Chen Yang; Aaron Tan
Journal:  Behav Brain Res       Date:  2015-04-20       Impact factor: 3.332

3.  Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics.

Authors:  P Sokoloff; B Giros; M P Martres; M L Bouthenet; J C Schwartz
Journal:  Nature       Date:  1990-09-13       Impact factor: 49.962

4.  Double-blind, randomized trial of bupropion SR for the treatment of neuropathic pain.

Authors:  M R Semenchuk; S Sherman; B Davis
Journal:  Neurology       Date:  2001-11-13       Impact factor: 9.910

5.  Suppression of voluntary wheel running in rats is dependent on the site of inflammation: evidence for voluntary running as a measure of hind paw-evoked pain.

Authors:  Peter M Grace; Keith A Strand; Steven F Maier; Linda R Watkins
Journal:  J Pain       Date:  2013-10-12       Impact factor: 5.820

6.  The putative dopamine D3 agonist, 7-OH-DPAT, reduces dopamine release in the nucleus accumbens and electrical self-stimulation to the ventral tegmentum.

Authors:  D B Gilbert; J Millar; S J Cooper
Journal:  Brain Res       Date:  1995-05-29       Impact factor: 3.252

7.  Signal valence in the nucleus accumbens to pain onset and offset.

Authors:  Lino Becerra; David Borsook
Journal:  Eur J Pain       Date:  2008-01-28       Impact factor: 3.931

Review 8.  Brain Reward Circuit and Pain.

Authors:  Moe Watanabe; Minoru Narita
Journal:  Adv Exp Med Biol       Date:  2018       Impact factor: 2.622

9.  Pain relief produces negative reinforcement through activation of mesolimbic reward-valuation circuitry.

Authors:  Edita Navratilova; Jennifer Y Xie; Alec Okun; Chaoling Qu; Nathan Eyde; Shuang Ci; Michael H Ossipov; Tamara King; Howard L Fields; Frank Porreca
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-26       Impact factor: 11.205

10.  Involvement of D2 receptor in the NAc in chronic unpredictable stress-induced depression-like behaviors.

Authors:  Hui Qiao; Sha Yang; Chang Xu; Xin-Ming Ma; Shu-Cheng An
Journal:  Stress       Date:  2019-10-06       Impact factor: 3.493

View more
  3 in total

Review 1.  Factors mediating pain-related risk for opioid use disorder.

Authors:  Arbi Nazarian; S Stevens Negus; Thomas J Martin
Journal:  Neuropharmacology       Date:  2021-01-30       Impact factor: 5.250

2.  Effects of chemotherapy on operant responding for palatable food in male and female mice.

Authors:  Julie A Meade; Alison N Fowlkes; Mackinsey J Wood; Mary Claire Kurtz; Madeline M May; Wisam B Toma; Urszula O Warncke; Jared Mann; Mohammed Mustafa; Aron H Lichtman; M Imad Damaj
Journal:  Behav Pharmacol       Date:  2021-08-01       Impact factor: 2.277

3.  Dopamine D2/3 Receptor Availabilities and Evoked Dopamine Release in Striatum Differentially Predict Impulsivity and Novelty Preference in Roman High- and Low-Avoidance Rats.

Authors:  Lidia Bellés; Andrea Dimiziani; Stergios Tsartsalis; Philippe Millet; François R Herrmann; Nathalie Ginovart
Journal:  Int J Neuropsychopharmacol       Date:  2021-03-17       Impact factor: 5.176

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.